Details for Patent: 11,564,912
✉ Email this page to a colleague
Which drugs does patent 11,564,912 protect, and when does it expire?
Patent 11,564,912 protects XIFAXAN and is included in one NDA.
This patent has thirty patent family members in fifteen countries.
Drugs Protected by US Patent 11,564,912
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 021361-002 | Mar 24, 2010 | RX | Yes | Yes | 11,564,912 | ⤷ Subscribe | TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULT FEMALE SUBJECTS AND SYMPTOMS THEREOF | ⤷ Subscribe | ||||
| Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 021361-002 | Mar 24, 2010 | RX | Yes | Yes | 11,564,912 | ⤷ Subscribe | TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULT FEMALE SUBJECTS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,564,912
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009219240 | ⤷ Subscribe | |||
| Australia | 2010292043 | ⤷ Subscribe | |||
| Brazil | 112012005627 | ⤷ Subscribe | |||
| Brazil | PI0908026 | ⤷ Subscribe | |||
| Canada | 2716578 | ⤷ Subscribe | |||
| Canada | 2773982 | ⤷ Subscribe | |||
| China | 101959412 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
